Elevated Dopamine D2/3 Receptor Availability in Obese Individuals: A PET Imaging Study with [11C](+)PHNO

Untitled work

(1998) · The Journal of Clinical Psychiatry · Cited by 19,139 · see citing works

Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single subject brain

Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319 · see citing works

Untitled work

(1998) · PubMed · Cited by 10,216 · see citing works

Unified segmentation

Ashburner, J., & Friston, K. J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.018 · Cited by 7,507 · see citing works

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866 · see citing works

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.

Flegal, K., Carroll, M., Kit, B., & Ogden, C. (2012) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2012.39 · Cited by 5,523 · see citing works

The Disease Burden Associated With Overweight and Obesity

Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,804 · see citing works

Consensus Nomenclature for <i>in vivo</i> Imaging of Reversibly Binding Radioligands

Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955 · see citing works

Brain dopamine and obesity

Wang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864 · see citing works

Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period

Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., Rimm, E., & Colditz, G. A. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1581 · Cited by 1,694 · see citing works

Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement

Dalley, J. W., Fryer, T. D., Brichard, L., Robinson, E. S. J., Theobald, D. E. H., Lääne, K., Peña, Y., Murphy, E. R., Shah, Y., Probst, K., et al. (2007) · Science · doi:10.1126/science.1137073 · Cited by 1,188 · see citing works

Increased baseline occupancy of D ₂ receptors by dopamine in schizophrenia

Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020 · see citing works

Low Level of Brain Dopamine D₂ Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex

Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916 · see citing works

Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography: I. Accuracy and Precision of D ₂ Receptor Parameter Measurements in Ventral Striatum

Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525 · see citing works

Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity

Val‐Laillet, D., Aarts, E., Weber, B., Ferrari, M., Quaresima, V., Stoeckel, L. E., Alonso‐Alonso, M., Audette, M. A., Malbert, C., & Stice, E. M. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.03.016 · Cited by 443 · see citing works

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy

Tziortzi, A. C., Searle, G. E., Tzimopoulou, S., Salinas, C. A., Beaver, J. D., Jenkinson, M., Laruelle, M. A., Rabiner, E. A., & Gunn, R. N. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.044 · Cited by 442 · see citing works

Noise Reduction in the Simplified Reference Tissue Model for Neuroreceptor Functional Imaging

Wu, Y., & Carson, R. (2002) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1097/01.wcb.0000033967.83623.34 · Cited by 440 · see citing works

Effects of chronic cocaine abuse on postsynaptic dopamine receptors

(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.6.719 · Cited by 421 · see citing works

Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity

Geiger, B. M., Haburcak, M., Avena, N. M., Moyer, M. C., Hoebel, B. G., & Pothos, E. N. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.007 · Cited by 403 · see citing works

Striatal Dopamine D ₂ /D ₃ Receptor Availability Is Reduced in Methamphetamine Dependence and Is Linked to Impulsivity

Lee, B., London, E. D., Poldrack, R. A., Farahi, J., Nacca, A., Monterosso, J. R., Mumford, J. A., Bokarius, A. V., Dahlbom, M., Mukherjee, J., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3765-09.2009 · Cited by 374 · see citing works

Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat

Davis, J. F., Tracy, A. L., Schurdak, J. D., Tschöp, M. H., Lipton, J. W., Clegg, D. J., & Benoit, S. C. (2008) · Behavioral Neuroscience · doi:10.1037/a0013111 · Cited by 307 · see citing works

Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior

Martinez, D., Broft, A., Foltin, R. W., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Frankel, W. G., Cooper, T., Kleber, H. D., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300420 · Cited by 306 · see citing works

Increasing Obesity Rates And Disability Trends

Sturm, R., Ringel, J. S., & Andreyeva, T. (2004) · Health Affairs · doi:10.1377/hlthaff.23.2.199 · Cited by 295 · see citing works

Association Between Age-Related Decline in Brain Dopamine Activity and Impairment in Frontal and Cingulate Metabolism

Volkow, N. D., Logan, J., Fowler, J. S., Wang, G., Gur, R. C., Wong, C., Felder, C. A., Gatley, S. J., Ding, Y., HITZEMANN, R. J., et al. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.75 · Cited by 286 · see citing works

Are The Young Becoming More Disabled?

Lakdawalla, D., Bhattacharya, J., & Goldman, D. P. (2004) · Health Affairs · doi:10.1377/hlthaff.23.1.168 · Cited by 270 · see citing works

Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT

Carson, R. E., Barker, W. C., Liow, J., & Johnson, C. A. (2004) · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) · doi:10.1109/nssmic.2003.1352597 · Cited by 269 · see citing works

Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans

Laruelle, M. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00043-2 · Cited by 266 · see citing works

Higher Binding of the Dopamine D 3 Receptor-Preferring Ligand [ 11 C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study

Boileau, I., Payer, D. E., Houle, S., Behzadi, A., Rusjan, P., Tong, J., Wilkins, D. G., Selby, P. L., George, T. P., Zack, M. H., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4371-11.2012 · Cited by 169 · see citing works

Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo

Narendran, R., Slifstein, M., Guillin, O., Hwang, Y., Hwang, D., Scher, E., Reeder, S., Rabiner, E. A., & Laruelle, M. A. (2006) · Synapse · doi:10.1002/syn.20325 · Cited by 167 · see citing works

Lower Level of Endogenous Dopamine in Patients With Cocaine Dependence: Findings From PET Imaging of D 2 /D 3 Receptors Following Acute Dopamine Depletion

Martínez, D., Greene, K. A., Broft, A. I., Kumar, D. J. S., Liu, F., Narendran, R., Slifstein, M., Heertum, R. V., & Kleber, H. D. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08121801 · Cited by 166 · see citing works

Within-Subject Comparison of [11C]-( + )-PHNO and [11C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans

Shotbolt, P., Tziortzi, A., Searle, G., Colasanti, A., van der Aart, J., Abanades, S., Plisson, C., Miller, S. R., Huiban, M., Beaver, J., et al. (2012) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/jcbfm.2011.115 · Cited by 156 · see citing works

Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist

Searle, G. E., Beaver, J. D., Comley, R. A., Bani, M., Tziortzi, A. C., Slifstein, M., Mugnaini, M., Griffante, C., Wilson, A. A., Merlo‐Pich, E., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.038 · Cited by 151 · see citing works

Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior

Guo, J., Simmons, W. K., Herscovitch, P., Martin, A. D., & Hall, K. D. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.102 · Cited by 148 · see citing works

Effects of intravenous glucose on dopaminergic function in the human brain in vivo

Haltia, L. T., Rinne, J. O., Merisaari, H., Maguire, R. P., Savontaus, E., Helin, S., Någren, K., & Kaasinen, V. (2007) · Synapse · doi:10.1002/syn.20418 · Cited by 148 · see citing works

Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using positron emission tomography

Ginovart, N., Galineau, L., Willeit, M., Mizrahi, R., Bloomfield, P. M., Seeman, P. M., Houle, S., Kapur, S., & Wilson, A. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03840.x · Cited by 146 · see citing works

High-Affinity States of Human Brain Dopamine D2/3 Receptors Imaged by the Agonist [11C]-(+)-PHNO

Willeit, M., Ginovart, N., Kapur, S., Houle, S., Hussey, D. F., Seeman, P. M., & Wilson, A. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.017 · Cited by 136 · see citing works

Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization

Ujike, H., Onoue, T., Akiyama, K., Hamamura, T., & Otsuki, S. (1989) · Psychopharmacology · doi:10.1007/bf00442011 · Cited by 136 · see citing works

Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment

Robertson, C. L., Ishibashi, K., Chudzynski, J. E., Mooney, L. J., Rawson, R. A., Dolezal, B. A., Cooper, C. B., Brown, A. K., Mandelkern, M. A., & London, E. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.331 · Cited by 136 · see citing works

Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity

Huang, X., Zavitsanou, K., Huang, X., Yu, Y., Wang, H., Chen, F., Lawrence, A. J., & Deng, C. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.08.034 · Cited by 134 · see citing works

Ventral and Dorsal Striatum Networks in Obesity: Link to Food Craving and Weight Gain

Contreras‐Rodríguez, O., Martín-Pérez, C., Vilar‐López, R., & Verdejo‐García, A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.020 · Cited by 131 · see citing works

Reduced accumbens dopamine in Sprague–Dawley rats prone to overeating a fat-rich diet

Rada, P. V., Bocarsly, M. E., Barson, J. R., Hoebel, B. G., & LEIBOWITZ, S. F. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.07.005 · Cited by 124 · see citing works

Dampened mesolimbic dopamine function and signaling by saturated but not monounsaturated dietary lipids

Hryhorczuk, C., Florea, M., Rodaros, D., Poirier, I., Daneault, C., Des Rosiers, C., Arvanitogiannis, A., Alquier, T., & Fulton, S. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.207 · Cited by 119 · see citing works

Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with [11C]-(+)-PHNO

Payer, D. E., Behzadi, A., Kish, S. J., Houle, S., Wilson, A. A., Rusjan, P., Tong, J., Selby, P. L., George, T. P., McCluskey, T., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.192 · Cited by 118 · see citing works

First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: a [11C]-(+)-PHNO positron emission tomography study

Willeit, M., Ginovart, N., Graff, A., Rusjan, P., Vitcu, I., Houle, S., Seeman, P., Wilson, A. A., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301400 · Cited by 107 · see citing works

Brain region binding of the D2/3 agonist [11C]‐(+)‐PHNO and the D2/3 antagonist [11C]raclopride in healthy humans

Graff‐Guerrero, A., Willeit, M., Ginovart, N., Mamo, D. C., Mizrahi, R., Rusjan, P., Vitcu, I., Seeman, P. M., Wilson, A. A., & Kapur, S. (2007) · Human Brain Mapping · doi:10.1002/hbm.20392 · Cited by 107 · see citing works

Small effect of dopamine release and no effect of dopamine depletion on [¹⁸F]fallypride binding in healthy humans

Cropley, V. L., Innis, R. B., Nathan, P. J., Brown, A. K., Sangare, J. L., Lerner, A., Ryu, Y. H., Sprague, K. E., Pike, V. W., & Fujita, M. (2008) · Synapse · doi:10.1002/syn.20506 · Cited by 104 · see citing works

Positron Emission Tomography Quantification of [ 11 C]-(+)-PHNO Binding in the Human Brain

Ginovart, N., Willeit, M., Rusjan, P., Graff, A., Bloomfield, P. M., Houle, S., Kapur, S., & Wilson, A. A. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600411 · Cited by 96 · see citing works

Regional analysis of age‐related decline in dopamine transporters and dopamine D2‐like receptors in human striatum

Ishibashi, K., Ishii, K., Oda, K., Kawasaki, K., Mizusawa, H., & Ishiwata, K. (2008) · Synapse · doi:10.1002/syn.20603 · Cited by 89 · see citing works

Affinity and selectivity of [11C]‐(+)‐PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo

Gallezot, J., Beaver, J. D., Gunn, R. N., Nabulsi, N., Weinzimmer, D. P., Singhal, T., Slifstein, M., Fowles, K., Ding, Y., Huang, Y. H., et al. (2011) · Synapse · doi:10.1002/syn.21535 · Cited by 86 · see citing works

A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with (N‐[11C]methyl)benperidol

Eisenstein, S. A., Antenor‐Dorsey, J. A. V., Gredysa, D. M., Koller, J. M., Bihun, E. C., Ranck, S. A., Arbeláez, A. M., Klein, S., Perlmutter, J. S., Moerlein, S. M., et al. (2013) · Synapse · doi:10.1002/syn.21680 · Cited by 85 · see citing works

Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO

Mizrahi, R., Agid, O., Borlido, C., Suridjan, I., Rusjan, P., Houle, S., Remington, G. J., Wilson, A. A., & Kapur, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.005 · Cited by 81 · see citing works

Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity

KESSLER, R. M., Zald, D. H., Ansari, M. S., Li, R., & Cowan, R. L. (2014) · Synapse · doi:10.1002/syn.21738 · Cited by 75 · see citing works

Dopamine D3 receptor alterations in cocaine-dependent humans imaged with [11C](+)PHNO

Matuskey, D., Gallezot, J., Pittman, B. P., Williams, W. A., Wanyiri, J. W., Gaiser, E., Lee, D. E., Hannestad, J. O., Lim, K., Zheng, M.-Q., et al. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.03.013 · Cited by 75 · see citing works

Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors

Yi, S.-J., & Johnson, K. M. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90241-9 · Cited by 65 · see citing works

Imaging the high-affinity state of the dopamine D2 receptor in vivo: Fact or fiction?

Skinbjerg, M., Sibley, D., Javitch, J., & Abi-Dargham, A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.008 · Cited by 63 · see citing works

Relation among dopamine D2 receptor binding, obesity and personality in normal human subjects

Yasuno, F., Suhara, T., Sudo, Y., Yamamoto, M., Inoue, M., Okubo, Y., & Suzuki, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01552-x · Cited by 61 · see citing works

Ventral Striatum Binding of a Dopamine D2/3 Receptor Agonist But Not Antagonist Predicts Normal Body Mass Index

Caravaggio, F., Raitsin, S., Gerretsen, P., Nakajima, S., Wilson, A. A., & Graff‐Guerrero, A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.017 · Cited by 60 · see citing works

Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum

Cosgrove, K., Veldhuizen, M. G., Sandiego, C. M., Morris, E. D., & Small, D. M. (2015) · Synapse · doi:10.1002/syn.21809 · Cited by 59 · see citing works

In Vivo Imaging of Cerebral Dopamine D3 Receptors in Alcoholism

Erritzøe, D., Tziortzi, A. C., Bargiela, D., Colasanti, A., Searle, G. E., Gunn, R. N., Beaver, J. D., Waldman, A. D., Nutt, D., Bani, M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.18 · Cited by 58 · see citing works

Parametric Imaging and Test–Retest Variability of11C-(+)-PHNO Binding to D2/D3Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner

Gallezot, J., Zheng, M., Lim, K., Lin, S.-F., Labaree, D. C., Matuskey, D., Huang, Y. H., Ding, Y., Carson, R. E., & Malison, R. T. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.132928 · Cited by 56 · see citing works

Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia

Sokoloff, P., Leriche, L., Díaz, J., Louvel, J., & Pumain, R. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0797-0 · Cited by 47 · see citing works

The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity

Thanos, P. K., Michaelides, M., Ho, C. W., Wang, G., Newman, A. H., Heidbreder, C. A., Ashby, C. R., Gardner, E. L., & Volkow, N. D. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.02.003 · Cited by 47 · see citing works

Age-related changes in binding of the D2/3 receptor radioligand [11C](+)PHNO in healthy volunteers

Matuskey, D., Worhunsky, P. D., Correa, E., Pittman, B. P., Gallezot, J., Nabulsi, N., Ropchan, J. R., Sreeram, V., Gudepu, R., Gaiser, E., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.002 · Cited by 47 · see citing works

Imaging Nicotine- and Amphetamine-Induced Dopamine Release in Rhesus Monkeys with [11C]PHNO vs [11C]raclopride PET

Gallezot, J., Kloczynski, T., Weinzimmer, D. P., Labaree, D. C., Zheng, M., Lim, K., Rabiner, E. A., Ridler, K., Pittman, B. P., Huang, Y. H., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.286 · Cited by 44 · see citing works

The D3 dopamine receptor: From structural interactions to function

Fiorentini, C., Savoia, P., Bono, F., Tallarico, P., & Missale, C. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.021 · Cited by 39 · see citing works

Effect of dopamine D3 receptor antagonism on approach responses to food cues in overweight and obese individuals

Mogg, K., Bradley, B. P., O’Neill, B. V., Bani, M., Merlo‐Pich, E., Koch, A., Bullmore, E. T., & Nathan, P. J. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283566a4a · Cited by 39 · see citing works

Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eaters

Dodds, C. M., O’Neill, B. V., Beaver, J. D., Makwana, A., Bani, M., Merlo‐Pich, E., Fletcher, P. C., Koch, A., Bullmore, E. T., & Nathan, P. J. (2012) · Appetite · doi:10.1016/j.appet.2012.03.007 · Cited by 39 · see citing works

Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam

Leggio, G. M., Torrisi, S. A., Castorina, A., Platania, C. B. M., Impellizzeri, A. A. R., Fidilio, A., Caraci, F., Bucolo, C., Drago, F., & Salomone, S. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.004 · Cited by 38 · see citing works

In Vivo Kinetics of [18F](N-Methyl)Benperidol: A Novel PET Tracer for Assessment of Dopaminergic D2-Like Receptor Binding

Moerlein, S. M., Perlmutter, J. S., Markham, J., & Welch, M. J. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199708000-00002 · Cited by 37 · see citing works

A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [11C](+)PHNO

Matuskey, D., Gaiser, E., Gallezot, J., Angarita, G. A., Pittman, B. P., Nabulsi, N., Ropchan, J. R., MaCleod, P., Cosgrove, K., Ding, Y., et al. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.06.039 · Cited by 36 · see citing works

Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [11C]-(+)-PHNO

Boileau, I., Nakajima, S., & Payer, D. E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.002 · Cited by 34 · see citing works

Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans

Seeman, P. M. (2011) · Synapse · doi:10.1002/syn.20987 · Cited by 32 · see citing works

Estimating Endogenous Dopamine Levels at D2 and D3 Receptors in Humans using the Agonist Radiotracer [11C]-(+)-PHNO

Caravaggio, F., Nakajima, S., Borlido, C., Remington, G. J., Gerretsen, P., Wilson, A. A., Houle, S., Menon, M., Mamo, D. C., & Graff‐Guerrero, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.125 · Cited by 32 · see citing works

Evidence for the heterotetrameric structure of the adenosine A2A–dopamine D2 receptor complex

Casadó-Anguera, V., Bonaventura, J., Moreno, E., Navarro, G., Cortés, A., Ferré, S., & Casadó, V. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150276 · Cited by 32 · see citing works

Diet-induced obesity and diet-resistant rats: differences in the rewarding and anorectic effects of d-amphetamine

Valenza, M., Steardo, L., Cottone, P., & Sabino, V. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3981-3 · Cited by 30 · see citing works

Regulation of novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in obesity: Novelty Seeking in Obesity

Savage, S. W., Zald, D. H., Cowan, R. L., Volkow, N. D., Marks-Shulman, P. A., Kessler, R. M., Abumrad, N. N., & Dunn, J. P. (2014) · Obesity · doi:10.1002/oby.20690 · Cited by 27 · see citing works

Lack of Age-Dependent Decrease in Dopamine D 3 Receptor Availability: A [ 11 C]-(+)-PHNO and [ 11 C]-Raclopride Positron Emission Tomography Study

Nakajima, S., Caravaggio, F., Boileau, I., Chung, J. K., Plitman, E., Gerretsen, P., Wilson, A. A., Houle, S., Mamo, D. C., & Graff‐Guerrero, A. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.129 · Cited by 27 · see citing works

Effects of age on dopamine D2 receptor availability in striatal subdivisions: A high-resolution positron emission tomography study

Kim, J., Son, Y., Kim, H.-K., Lee, S., Cho, S., Kim, Y.-B., & Cho, Z. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.009 · Cited by 24 · see citing works

Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049

Culver, K. E., Szechtman, H., & Levant, B. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.101 · Cited by 16 · see citing works

Concurrently upregulated and downregulated D2/D3 receptor systems in cocaine use disorder using [11C]PHNO

Worhunsky, P. D., Matuskey, D., Gallezot, J., Gaiser, E., Nabulsi, N., Angarita, G. A., Calhoun, V. D., Malison, R. T., Potenza, M. N., & Carson, R. E. (2016) · Journal of Nuclear Medicine · Cited by 1 · see citing works

Brain–gut–microbiome interactions in obesity and food addiction

Gupta, A., Osadchiy, V., & Mayer, E. A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0341-5 · Cited by 268 · see citing works

Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging

Matuskey, D., Tinaz, S., Wilcox, K. C., Naganawa, M., Toyonaga, T., Dias, M., Henry, S. E., Pittman, B. P., Ropchan, J. R., Nabulsi, N., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25682 · Cited by 180 · see citing works

The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies

van Galen, K. A., ter Horst, K. W., Booij, J., la Fleur, S. E., & Serlie, M. J. M. (2017) · Metabolism · doi:10.1016/j.metabol.2017.09.007 · Cited by 111 · see citing works

First-in-Human Assessment of ¹¹C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer

Naganawa, M., Nabulsi, N., Henry, S., Matuskey, D., Lin, S.-F., Slieker, L., Schwarz, A. J., Kant, N., Jesudason, C., Ruley, K., et al. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.246967 · Cited by 94 · see citing works

Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson’s disease

de Laat, B., Hoye, J., Stanley, G., Hespeler, M., Ligi, J., Mohan, V., Wooten, D., Zhang, X., Nguyen, T. D., Key, J., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00641-1 · Cited by 83 · see citing works

Age-Related Change in 5-HT 6 Receptor Availability in Healthy Male Volunteers Measured with 11 C-GSK215083 PET

Radhakrishnan, R., Nabulsi, N., Gaiser, E., Gallezot, J., Henry, S. E., Planeta, B. M., Lin, S.-F., Ropchan, J. R., Williams, W. A., Morris, E. D., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.206516 · Cited by 82 · see citing works

The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics

Boswell, R. G., Potenza, M. N., & Grilo, C. M. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.10.014 · Cited by 82 · see citing works

Nucleus accumbens D1- and D2-expressing neurons control the balance between feeding and activity-mediated energy expenditure

Walle, R., Petitbon, A., Fois, G. R., Varin, C., Montalban, E., Hardt, L., Contini, A., Angelo, M. F., Potier, M., Ortolé, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46874-9 · Cited by 53 · see citing works

Do Dopaminergic Impairments Underlie Physical Inactivity in People with Obesity?

Kravitz, A. V., O’Neal, T. J., & Friend, D. M. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00514 · Cited by 48 · see citing works

History of early life adversity is associated with increased food addiction and sex-specific alterations in reward network connectivity in obesity

Osadchiy, V., Mayer, E. A., Bhatt, R., Labus, J. S., Gao, L., Kilpatrick, L. A., Liu, C., Tillisch, K., Naliboff, B., Chang, L., et al. (2019) · Obesity Science &amp; Practice · doi:10.1002/osp4.362 · Cited by 44 · see citing works

In vivo 5-HT6 and 5-HT2A receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [11C]GSK215083 PET

Radhakrishnan, R., Matuskey, D., Nabulsi, N., Gaiser, E., Gallezot, J., Henry, S. E., Planeta, B. M., Lin, S.-F., Ropchan, J. R., Huang, Y. H., et al. (2019) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2019.111007 · Cited by 41 · see citing works

Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers

Matuskey, D., Dias, M., Naganawa, M., Pittman, B. P., Henry, S. E., Li, S., Gao, H., Ropchan, J. R., Nabulsi, N., Carson, R. E., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0379-7 · Cited by 38 · see citing works

Molecular Imaging of Central Dopamine in Obesity: A Qualitative Review across Substrates and Radiotracers

Janssen, L. K., & Horstmann, A. (2022) · Brain Sciences · doi:10.3390/brainsci12040486 · Cited by 36 · see citing works

Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis

Ribeiro, G., Maia, A. C. C. D. O., Cotovio, G., Oliveira, F. P. M., Costa, D. C., & Oliveira-Maia, A. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-31250-2 · Cited by 33 · see citing works

Early Life Stress and the Onset of Obesity: Proof of MicroRNAs’ Involvement Through Modulation of Serotonin and Dopamine Systems’ Homeostasis

Tavares, G. A., Torres, A., & de Souza, J. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00925 · Cited by 28 · see citing works

Nucleus accumbens volume is related to obesity measures in an age‐dependent fashion

García‐García, I., Morys, F., & Dagher, A. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12812 · Cited by 28 · see citing works

Role of the striatal dopamine, GABA and opioid systems in mediating feeding and fat intake

Joshi, A., Schott, M., la Fleur, S. E., & Barrot, M. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104726 · Cited by 28 · see citing works

Dopamine Adaptations as a Common Pathway for Neurocognitive Impairment in Diabetes and Obesity: A Neuropsychological Perspective

Small, D. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00134 · Cited by 27 · see citing works

Decrease in Operant Responding Under Obesogenic Diet Exposure is not Related to Deficits in Incentive or Hedonic Processes

Ducrocq, F., Hyde, A., Fanet, H., Oummadi, A., Walle, R., Smedt, V. D., Layé, S., Ferreira, G., Trifilieff, P., & Vancassel, S. (2018) · Obesity · doi:10.1002/oby.22358 · Cited by 20 · see citing works

Lost in Translation? On the Need for Convergence in Animal and Human Studies on the Role of Dopamine in Diet-Induced Obesity

Janssen, L. K., Herzog, N., Waltmann, M., Breuer, N., Wiencke, K., Rausch, F., Hartmann, H., Poessel, M., & Horstmann, A. (2019) · Current Addiction Reports · doi:10.1007/s40429-019-00268-w · Cited by 20 · see citing works

Food Addiction, Skating on Thin Ice: a Critical Overview of Neuroimaging Findings

García‐García, I., Morys, F., Michaud, A., & Dagher, A. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00293-0 · Cited by 17 · see citing works

Kynurenic acid, an aryl hydrocarbon receptor ligand, is elevated in serum of Zucker fatty rats.

Oxenkrug, G. F., Cornicelli, J. A., van der Hart, M., Roeser, J., & D, P. S. M. (2016) · PubMed · Cited by 16 · see citing works

Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta‐analyses

Pak, K., & Nummenmaa, L. (2023) · Human Brain Mapping · doi:10.1002/hbm.26534 · Cited by 15 · see citing works

The relationship between subcortical brain volume and striatal dopamine D2/3receptor availability in healthy humans assessed with [11C]‐raclopride and [11C]‐(+)‐PHNO PET

Caravaggio, F., Chung, J. K., Plitman, E., Boileau, I., Gerretsen, P., Kim, J., Iwata, Y., Patel, R., Chakravarty, M. M., Remington, G. J., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23744 · Cited by 15 · see citing works

Striatal dopamine transporter changes after glucose loading in humans

Pak, K., Seo, S., Keun-young Kim, A., Lee, M. J., Shin, M., Suh, S., Im, H., Park, J., Kim, S., & Kim, I. J. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13872 · Cited by 14 · see citing works

Investigating dopaminergic abnormalities in schizophrenia and first-episode psychosis with normative modelling and multisite molecular neuroimaging

Giacomel, A., Martins, D., Nordio, G., Easmin, R., Howes, O. D., Selvaggi, P., Williams, S., Turkheimer, F., de Groot, M., Dipasquale, O., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02938-w · Cited by 10 · see citing works

Effects of bariatric surgery and dietary interventions for obesity on brain neurotransmitter systems and metabolism: A systematic review of positron emission tomography (PET) and single‐photon emission computed tomography (SPECT) studies

Al‐Alsheikh, A. S., Alabdulkader, S., Miras, A. D., & Goldstone, A. P. (2023) · Obesity Reviews · doi:10.1111/obr.13620 · Cited by 10 · see citing works

Dopamine receptor and dopamine transporter in obesity: A meta‐analysis

Pak, K., Seok, J. W., Lee, M. J., Keun-young Kim, A., & Kim, I. J. (2022) · Synapse · doi:10.1002/syn.22254 · Cited by 10 · see citing works

Expression of Dopamine-Related Genes in Four Human Brain Regions

Stanfill, A. G., & Cao, X. (2020) · Brain Sciences · doi:10.3390/brainsci10080567 · Cited by 10 · see citing works

Striatal dopamine tone is positively associated with adiposity in humans as determined by PET using dual dopamine type-2 receptor antagonist tracers

Darcey, V. L., Guo, J., Chi, M., Chung, S. T., Courville, A. B., Gallagher, I., Herscovitch, P., Howard, R., LaNoire, M., Milley, L., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02960-y · Cited by 18 · see citing works

Striatal dopamine tone is positively associated with body mass index in humans as determined by PET using dual dopamine type-2 receptor antagonist tracersPreprint

Darcey, V. L., Guo, J., Chi, M., Chung, S. T., Courville, A. B., Gallagher, I., Herscovitch, P., Howard, R., LaNoire, M., Milley, L., et al. (2023) · medRxiv · doi:10.1101/2023.09.27.23296169 · Cited by 9 · see citing works

Midbrain and Lateral Nucleus Accumbens Dopamine Depletion Affects Free-choice High-fat high-sugar Diet Preference in Male Rats

Joshi, A., Faivre, F., la Fleur, S. E., & Barrot, M. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.05.022 · Cited by 8 · see citing works

Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia

Sauerzopf, U., Weidenauer, A., Dajić, I., Bauer, M., Bartova, L., Meyer, B., Nics, L., Philippe, C., Pfaff, S., Pichler, V., et al. (2021) · NeuroImage: Clinical · doi:10.1016/j.nicl.2021.102813 · Cited by 7 · see citing works

Transistor chaining and transistor reordering in the design of CMOS complex gates

Carlson, B. S. (1992) · Cited by 8 · see citing works

Abundance of dopamine and its receptors in the brain and adipose tissue following diet-induced obesity or caloric restriction

Hukema, F., Hetty, S., Kagios, C., Zelleroth, S., Fanni, G., Pereira, M. J., Svensson, M. K. E., Sundbom, M., Nilsson, A., Andrén, P. E., et al. (2025) · Translational research · doi:10.1016/j.trsl.2025.05.001 · Cited by 8 · see citing works

Neuroimaging and modulation in obesity and diabetes research: 10th anniversary meeting

Laughlin, M. R., Cooke, B., Boutelle, K. N., Savage, C. R., Kravitz, A. V., Small, D. M., Arvanitakis, Z., Martin, A. D., & Stoeckel, L. E. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-01025-8 · Cited by 7 · see citing works

Toward the Optimization of (+)-[11C]PHNO Synthesis: Time Reduction and Process Validation

Pfaff, S., Philippe, C., Nics, L., Berroterán-Infante, N., Pallitsch, K., Rami-Mark, C., Weidenauer, A., Sauerzopf, U., Willeit, M., Mitterhauser, M., et al. (2019) · Contrast Media & Molecular Imaging · doi:10.1155/2019/4292596 · Cited by 7 · see citing works

The historical progression of positron emission tomography research in neuroendocrinology

Bini, J. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101081 · Cited by 6 · see citing works

Central dopamine receptors: Radiotracers unveiling the Role of dopaminergic tone in obesity

Pais, M. L., Crisóstomo, J., Abrunhosa, A., & Castelo-Branco, M. S. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02501-0 · Cited by 4 · see citing works

Dopamine D2/3 receptor availability in cocaine use disorder individuals with obesity as measured by [11C]PHNO PET

Matuskey, D., Angarita, G. A., Worhunsky, P. D., Koohsari, S., Gravel, P., Pittman, B. P., Gaiser, E., Gallezot, J.-D., Nabulsi, N., Huang, Y. H., et al. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108514 · Cited by 4 · see citing works

Operant Training for Highly Palatable Food Alters Translating Messenger RNA in Nucleus Accumbens D2 Neurons and Reveals a Modulatory Role of Ncdn

Montalban, E., Giralt, A., Taing, L., Nakamura, Y., Pelosi, A., Brown, M., de Pins, B., Valjent, E., Martín, M., Nairn, A. C., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.08.006 · Cited by 3 · see citing works

Obesity: An Addiction? Imaging of Neurotransmitter Systems in Obesity

van de Giessen, E., McIlwrick, S., Veltman, D. J., van den Brink, W., & Booij, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_26 · Cited by 3 · see citing works

Exploring seasonal fluctuations in dopamine D2/D3 receptor availability in healthy adults: A [11C]PHNO imaging study

Mayeli, M., Gallezot, J., Cosgrove, K., Potenza, M. N., Carson, R. E., & Matuskey, D. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120293 · Cited by 2 · see citing works

D3 Receptors and PET Imaging

Koohsari, S., Yang, Y., & Matuskey, D. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_374 · Cited by 2 · see citing works

Further in vivo characterization of [11C]‐(+)‐PHNO uptake into a retina‐like region of interest in humans

Caravaggio, F., Worhunsky, P. D., Graff‐Guerrero, A., & Matuskey, D. (2019) · Synapse · doi:10.1002/syn.22135 · Cited by 2 · see citing works

Rôle de l’axe microbiote-intestin-cerveau dans la dérégulation du comportement alimentaire au cours de l’obésité et de l’hyperphagie boulimique : les mécanismes

Galmiche, M. C., & Déchelotte, P. (2023) · Nutrition Clinique et Métabolisme · doi:10.1016/s0985-0562(24)00007-4 · Cited by 1 · see citing works

PET/fMRI demonstrates that bariatric surgery may reverse striatal dopaminergic dysfunction in women with obesity

Pais, M. L., Crisóstomo, J., Abrunhosa, A., & Castelo-Branco, M. S. (2025) · Communications Medicine · doi:10.1038/s43856-025-01079-z · Cited by 1 · see citing works

Effects of Age and BMI on Histamine H3 Receptor Availability in Healthy Humans

Yang, Y., Ibrahim, W., Gravel, P., Pittman, B. P., Hoye, J., Cool, R., Sadabad, F. E., Zheng, M., Pittenger, C., Gallezot, J., et al. (2025) · Molecular Imaging and Biology · doi:10.1007/s11307-025-02047-8 · Cited by 1 · see citing works

Dose reduction for synaptic density PET imaging in Parkinson’s disease

Li, A., Naganawa, M., Honhar, P., Fontaine, K. M., Gravel, P., Matuskey, D., Carson, R. E., & Tang, J. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.121853 · Cited by 1 · see citing works

Kappa opioid receptor availability correlates with depressive symptom burden in chronic migraine: a preliminary investigation

Kim, D. J., Saberi, M., Kaur, T., Shao, X., Koeppe, R. A., Scott, P. J. H., Porreca, F., & DaSilva, A. F. M. (2026) · The Journal of Headache and Pain · doi:10.1186/s10194-026-02398-9 · Cited by 1 · see citing works

Investigating Dopaminergic Abnormalities in Psychosis with Normative Modelling and Multisite Molecular NeuroimagingPreprint

Giacomel, A., Martins, D., Nordio, G., Easmin, R., Howes, O. D., Selvaggi, P., Williams, S., Turkheimer, F., de Groot, M., Dipasquale, O., et al. (2023) · medRxiv · doi:10.1101/2023.11.27.23299051 · Cited by 1 · see citing works

Dopamine receptors in obesity: a meta-analysisPreprint

Pak, K., Lee, M. J., Keun-young Kim, A., & Kim, I. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.29.424782

Applications, Advances, and Limitations of Molecular Imaging of Brain Receptors

Cumming, P. D., Gründer, G., Brinson, Z. S., & Wong, D. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00063-6

Faculty Opinions recommendation of Synaptic changes in Parkinson's disease assessed with in-vivo imaging.

Caviness, J. N. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737231678.793570128

Dietary interventions for the real world? Addressing hedonic appetite and impulsive eating behaviours in the digital age

Moore, H. (2022) · Queensland University of Technology · doi:10.5204/thesis.eprints.235040

Neurocircuitry Underlying the Addictive Dimension of Overeating and Obesity

Dennis, E., Johnson, A., Sotelo, D., Vines, L., Manza, P., Wang, G., & Volkow, N. D. (2024) · doi:10.1093/oso/9780190671051.003.0050

The Change of Dopamine Transporter After Glucose Loading Is Associated With an Individual's Attitude Toward Sweet Foods in Healthy Young Males

Pak, K., Kim, J., Kim, K., Seo, S., & Lee, M. J. (2025) · Human Brain Mapping · doi:10.1002/hbm.70426

Vulnérabilité du réseau neuronal du noyau accumbens à la déficience développementale en acides gras polyinsaturés n-3 : conséquences sur le système de récompense et de motivation

Ducrocq, F. (2018) · theses.fr (ABES) · doi:10.70675/0d7955a2za2d9z49e3z9613z2271f5ed839a

Le rôle respectif des différents populations de neurones épineux moyens du noyau accumbens dans la motivation et la prise alimentaire

Walle, R. (2021) · theses.fr (ABES) · doi:10.70675/4121b221z3107z40a2za0dfz06b8fde8c4b0

Dopamine D2/3 receptor availability in cocaine use disorder individuals with obesity as measured by [11C]PHNO PET

Matuskey, D., Angarita, G. A., Worhunsky, P. D., Koohsari, S., Gravel, P., Pittman, B. P., Gaiser, E., Gallezot, J.-D., Nabulsi, N., Huang, Y. H., et al. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108514 · Cited by 4 · see citing works

Ventral Striatum Binding of a Dopamine D2/3 Receptor Agonist But Not Antagonist Predicts Normal Body Mass Index

Caravaggio, F., Raitsin, S., Gerretsen, P., Nakajima, S., Wilson, A. A., & Graff‐Guerrero, A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.017 · Cited by 60 · see citing works

A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with (N‐[11C]methyl)benperidol

Eisenstein, S. A., Antenor‐Dorsey, J. A. V., Gredysa, D. M., Koller, J. M., Bihun, E. C., Ranck, S. A., Arbeláez, A. M., Klein, S., Perlmutter, J. S., Moerlein, S. M., et al. (2013) · Synapse · doi:10.1002/syn.21680 · Cited by 85 · see citing works

Dopamine receptors in obesity: a meta-analysisPreprint

Pak, K., Lee, M. J., Keun-young Kim, A., & Kim, I. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.29.424782

Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects

de Weijer, B. A., van de Giessen, E., van Amelsvoort, T. A., Boot, E., Braak, B., Janssen, I. M., van de Laar, A., Fliers, E., Serlie, M. J., & Booij, J. (2011) · EJNMMI Research · doi:10.1186/2191-219x-1-37 · Cited by 176 · see citing works